Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1994 Oct;53(10):681–684. doi: 10.1136/ard.53.10.681

Bone mineral density in nonsteroid treated early rheumatoid arthritis.

B D Shenstone 1, A Mahmoud 1, R Woodward 1, D Elvins 1, R Palmer 1, F Ring 1, A K Bhalla 1
PMCID: PMC1005436  PMID: 7979582

Abstract

OBJECTIVES--To determine whether significant reduction in bone mass is detectable in early disease in patients with rheumatoid arthritis (RA) and to examine the possible influences of disease activity and physical disability on bone mineral density (BMD) of the lumbar spine (LS) and femoral neck (FN). METHODS--LS and FN BMD values were measured and Z scores determined in a cross-sectional study of 104 patients with RA of less than five years duration. BMD values were also compared between a subgroup of 64 patients and a normal control group matched for age, sex, menopausal status and body mass. BMD values and Z scores were correlated with disease activity, measured by the Stoke Index, disability, measured by HAQ score, and disease duration. RESULTS--Premenopausal female patients with RA had significantly reduced mean FN Z scores (-0.62, 95% CI -0.30 to -0.94) which correlated with HAQ scores (Rs 0.358, p = 0.05) and age (Rs 0.397, p = 0.03). There were no significant changes of BMD in males or postmenopausal females. Disease duration and disease activity did not correlate with BMD changes. CONCLUSION--BMD is reduced in premenopausal female patients with early RA possibly related to the attainment of peak bone mass. No significant reduction of BMD was found in males or postmenopausal females with early disease. Physical disability but not disease activity appears to play a role in the reduction of FN bone mass.

Full text

PDF
684

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Als O. S., Gotfredsen A., Riis B. J., Christiansen C. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis? Ann Rheum Dis. 1985 Jun;44(6):406–411. doi: 10.1136/ard.44.6.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Compston J. E., Crawley E. O., Evans C., O'Sullivan M. M. Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis. 1988 Aug;47(8):660–664. doi: 10.1136/ard.47.8.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. D'Angelo A., Fabris A., Sartori L., Malvasi L., Travaglia P., Gambari P. F., Todesco S. Mineral metabolism and bone mineral content in rheumatoid arthritis. Effect of corticosteroids. Clin Exp Rheumatol. 1985 Apr-Jun;3(2):143–146. [PubMed] [Google Scholar]
  5. Kirwan J. R., Reeback J. S. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol. 1986 May;25(2):206–209. doi: 10.1093/rheumatology/25.2.206. [DOI] [PubMed] [Google Scholar]
  6. Laan R. F., Buijs W. C., Verbeek A. L., Draad M. P., Corstens F. H., van de Putte L. B., van Riel P. L. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis. 1993 Jan;52(1):21–26. doi: 10.1136/ard.52.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Laan R. F., van Riel P. L., van Erning L. J., Lemmens J. A., Ruijs S. H., van de Putte L. B. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol. 1992 Feb;31(2):91–96. doi: 10.1093/rheumatology/31.2.91. [DOI] [PubMed] [Google Scholar]
  8. Magaro M., Tricerri A., Piane D., Zoli A., Serra F., Altomonte L., Mirone L. Generalized osteoporosis in non-steroid treated rheumatoid arthritis. Rheumatol Int. 1991;11(2):73–76. doi: 10.1007/BF00291149. [DOI] [PubMed] [Google Scholar]
  9. O'Malley M., Kenrick A. J., Sartoris D. J., Hochberg A. M., Weisman M. H., Ramos E., Zvaifler N., Resnick D. Axial bone density in rheumatoid arthritis: comparison of dual-energy projection radiography and dual-photon absorptiometry. Radiology. 1989 Feb;170(2):501–505. doi: 10.1148/radiology.170.2.2911675. [DOI] [PubMed] [Google Scholar]
  10. Pocock N. A., Eisman J. A., Mazess R. B., Sambrook P. N., Yeates M. G., Freund J. Bone mineral density in Australia compared with the United States. J Bone Miner Res. 1988 Dec;3(6):601–604. doi: 10.1002/jbmr.5650030604. [DOI] [PubMed] [Google Scholar]
  11. Reid D. M., Kennedy N. S., Smith M. A., Tothill P., Nuki G. Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) 1982 Jul 31;285(6338):330–332. doi: 10.1136/bmj.285.6338.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  13. Sambrook P. N., Eisman J. A., Champion G. D., Yeates M. G., Pocock N. A., Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum. 1987 Jul;30(7):721–728. doi: 10.1002/art.1780300701. [DOI] [PubMed] [Google Scholar]
  14. Sambrook P. N., Eisman J. A., Yeates M. G., Pocock N. A., Eberl S., Champion G. D. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis. 1986 Nov;45(11):950–953. doi: 10.1136/ard.45.11.950. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES